2 Clarke Drive
Suite 100
Cranbury, NJ 08512
© 2024 MJH Life Sciences™ and OncLive - Clinical Oncology News, Cancer Expert Insights. All rights reserved.
Andre Goy, MD, MS, chairman, director, and chief of the Lymphoma Division at the John Theurer Cancer Center, discusses NCCN guidelines for the treatment of lymphomas.
Andre Goy, MD, MS, chairman, director, and chief of the Lymphoma Division at the John Theurer Cancer Center, discusses NCCN guidelines for the treatment of lymphomas.
NCCN guidelines are updated frequently now, Goy says, and do a great job of trying to integrate novel therapies early on. As there are many options for every lymphoma, guidelines try to unify physicians in their diagnosis and treatment methods.
Treatment of lymphomas is not homogenous, Goy says, and there remains a need to better stratify patients on biological signature in a more reliable way to streamline guidelines and pinpoint better choices.
Related Content: